Page 45 - TD-3-3
P. 45

Tumor Discovery                                                    LncRNA HA117 in osteosarcoma regulation



            states, suggesting that HA117 may  serve  as a  potential   Writing – original draft: Xiaoping Huang, Hongxia Chen
            therapeutic target for osteosarcoma research. This finding   Writing – review & editing: Ning Wang
            is consistent with previous studies in leukemia. HA117
            can affect the expression of a large number of downstream   Ethics approval and consent to participate
            target genes through trans-regulation, involving functions   Not applicable.
            such as metabolic immunity and cellular stress stimulation.
            Meanwhile, due to the lack of miRNA data, it is currently   Consent for publication
            unclear which miRNAs can adsorb HA117 and form a   Not applicable.
            sponge effect. Therefore, additional experiments are needed
            to confirm the relationships among HA117, miRNA, and   Availability of data
            mRNA.
                                                               Raw data can be obtained from the NCBI SRA database
            5. Conclusion                                      under the accession number PRJNA389279.

            By re-analyzing 36 fresh samples and 15 FFPE samples   References
            containing the lncRNA HA117 in osteosarcoma, we found
            no difference in HA117 expression between the tumor and   1.   Bernardini G, Laschi M, Geminiani M, Santucci A.
                                                                  Proteomics of osteosarcoma.  Expert Rev Proteomics.
            adjacent tissues. However, HA117 exhibited significant   2014;11(3):331-343.
            down-regulation before and after chemotherapy. We then
            combined two methods to predict 11 and 83 target genes of      doi: 10.1586/14789450.2014.900445
            HA117 in fresh and FFPE samples, respectively. GO analysis   2.   Chen R, Huang LH, Gao YY, Yang JZ, Wang Y. Identification
            showed that these target genes are mainly located in the   of differentially expressed genes in MG63 osteosarcoma
            cytoplasm and nucleus, and are related to protein binding. In   cells with drug-resistance by microarray analysis. Mol Med
            addition, 17 genes were found to be related to extracellular   Rep. 2019;19(3):1571-1580.
            exosomes. Reactome analysis revealed that these genes      doi: 10.3892/mmr.2018.9774
            were significantly enriched in four pathways: Interferon-  3.   Karadurmus N, Sahin U, Bahadir Basgoz B, Demirer T. Is
            alpha/beta signaling, cellular responses to stress, cellular   there a role of high dose chemotherapy and autologous stem
            responses to stimuli, and cellular responses to activation.   cell transplantation in the treatment of Ewing’s sarcoma and
            Subsequently, survival analysis on 11 key target genes of   osteosarcomas? J Buon. 2018;23(5):1235-1241.
            HA117 indicated that low expression  BCL7A,  NISCH,
            and  PGD was beneficial for the survival of osteosarcoma   4.   Moore  DD,  Luu  HH.  Osteosarcoma.  Cancer Treat Res.
                                                                  2014;162:65-92.
            patients. These results suggest that HA117 may play a role in
            the response to chemotherapy and is a potential therapeutic      doi: 10.1007/978-3-319-07323-1_4
            target in osteosarcoma. However, these transcriptome data   5.   Tamari K, Hayashi K, Ishii H,  et al. Identification of
            are limited, and further research is needed to elucidate the   chemoradiation-resistant  osteosarcoma stem  cells using
            regulatory mechanisms between HA117 and target genes.  an imaging system for proteasome activity.  Int J Oncol.
                                                                  2014;45(6):2349-2354.
            Acknowledgments                                       doi: 10.3892/ijo.2014.2671
            None.                                              6.   Gorlick R. Current concepts on the molecular biology of
                                                                  osteosarcoma. Cancer Treat Res. 2009;152:467-478.
            Funding
                                                                  doi: 10.1007/978-1-4419-0284-9_27
            This  research  was  funded  by  the  Natural  Science
            Foundation of Chongqing, Project number cstc2020jcyj-  7.   Gorlick R, Khanna C. Osteosarcoma.  J  Bone Miner Res.
                                                                  2010;25(4):683-691.
            msxmX0966.
                                                                  doi: 10.1002/jbmr.77
            Conflict of interest                               8.   Zhou G, Shi X, Zhang J, Wu S, Zhao J. MicroRNAs
            The authors declare no competing interests.           in osteosarcoma: From biological players to clinical
                                                                  contributors, a review. J Int Med Res. 2013;41(1):1-12.
            Author contributions                                  doi: 10.1177/0300060513475959
            Conceptualization: Hongxia Chen, Ning Wang         9.   Du X, Yang J, Yang D, Tian W, Zhu Z. The genetic basis for
            Investigation: Zhiyong Cheng                          inactivation of Wnt pathway in human osteosarcoma. BMC
            Methodology: Wei Wang, Zhenhua Zhuang                 Cancer. 2014;14:450.


            Volume 3 Issue 3 (2024)                         11                                doi: 10.36922/td.3670
   40   41   42   43   44   45   46   47   48   49   50